Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,038 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Non-invasive testing for sarcopenia predicts future cardiovascular events in patients with chronic kidney disease.
Hanatani S, Izumiya Y, Onoue Y, Tanaka T, Yamamoto M, Ishida T, Yamamura S, Kimura Y, Araki S, Arima Y, Nakamura T, Fujisue K, Takashio S, Sueta D, Sakamoto K, Yamamoto E, Kojima S, Kaikita K, Tsujita K. Hanatani S, et al. Among authors: kimura y. Int J Cardiol. 2018 Oct 1;268:216-221. doi: 10.1016/j.ijcard.2018.03.064. Epub 2018 Apr 9. Int J Cardiol. 2018. PMID: 29650344
Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
Izumiya Y, Hanatani S, Kimura Y, Takashio S, Yamamoto E, Kusaka H, Tokitsu T, Rokutanda T, Araki S, Tsujita K, Tanaka T, Yamamuro M, Kojima S, Tayama S, Kaikita K, Hokimoto S, Ogawa H. Izumiya Y, et al. Among authors: kimura y. Can J Cardiol. 2014 Mar;30(3):338-44. doi: 10.1016/j.cjca.2013.12.010. Epub 2013 Dec 18. Can J Cardiol. 2014. PMID: 24484911
Circulating thrombospondin-2 reflects disease severity and predicts outcome of heart failure with reduced ejection fraction.
Hanatani S, Izumiya Y, Takashio S, Kimura Y, Araki S, Rokutanda T, Tsujita K, Yamamoto E, Tanaka T, Yamamuro M, Kojima S, Tayama S, Kaikita K, Hokimoto S, Ogawa H. Hanatani S, et al. Among authors: kimura y. Circ J. 2014;78(4):903-10. doi: 10.1253/circj.cj-13-1221. Epub 2014 Feb 6. Circ J. 2014. PMID: 24500070 Free article. Clinical Trial.
HE4 Predicts Progressive Fibrosis and Cardiovascular Events in Patients With Dilated Cardiomyopathy.
Yamamoto M, Hanatani S, Araki S, Izumiya Y, Yamada T, Nakanishi N, Ishida T, Yamamura S, Kimura Y, Arima Y, Nakamura T, Takashio S, Yamamoto E, Sakamoto K, Kaikita K, Matsushita K, Morimoto S, Ito T, Tsujita K. Yamamoto M, et al. Among authors: kimura y. J Am Heart Assoc. 2021 Aug 3;10(15):e021069. doi: 10.1161/JAHA.120.021069. Epub 2021 Jul 29. J Am Heart Assoc. 2021. PMID: 34320813 Free PMC article.
Reduced trans-mitral A-wave velocity predicts the presence of wild-type transthyretin amyloidosis in elderly patients with left ventricular hypertrophy.
Yamamura S, Izumiya Y, Ishida T, Onoue Y, Kimura Y, Hanatani S, Araki S, Fujisue K, Sueta D, Kanazawa H, Takashio S, Usuku H, Sugamura K, Sakamoto K, Yamamoto E, Yamamuro M, Yasuda H, Kojima S, Kaikita K, Hokimoto S, Ogawa H, Tsujita K. Yamamura S, et al. Among authors: kimura y. Heart Vessels. 2017 Jun;32(6):708-713. doi: 10.1007/s00380-016-0925-8. Epub 2016 Nov 23. Heart Vessels. 2017. PMID: 27882404
6,038 results